Transcutaneous auricular vagus nerve stimulation for chronic insomnia disorder: a randomized clinical trial
Zhang S, Zhao Y, Qin Z, Han Y, He J, Zhao B, Wang L, Duan Y, Huo J, Wang T, et al.
JAMA Network Open · 2024
Key finding
Active taVNS achieved a mean PSQI reduction of 8.2 points versus 3.9 for sham (Cohen's d = 1.2) in chronic insomnia, with benefits sustained over 20 weeks and no serious adverse effects.
- Condition
- Sleep
- Stimulation
- taVNS
- Evidence tier
- Randomised Controlled Trial
- Participants
- 72
Cite this study
Zhang, S., Zhao, Y., Qin, Z., Han, Y., He, J., Zhao, B., Wang, L., Duan, Y., Huo, J., Wang, T., Wang, Y., & Rong, P. (2024). Transcutaneous auricular vagus nerve stimulation for chronic insomnia disorder: a randomized clinical trial. JAMA Network Open, 7(12), e2451217. https://doi.org/10.1001/jamanetworkopen.2024.51217
Related studies in Sleep
Transcutaneous auricular vagus nerve stimulation in insomnia: a systematic review and meta-analysis
De Oliveira et al. · Neuromodulation · 2025 · Systematic Review / Meta-Analysis
The Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Sleep Quality in Insomnia: a Systematic Review and Meta-analysis
Hasani et al. · Current Sleep Medicine Reports · 2025 · Systematic Review / Meta-Analysis
Is transcutaneous auricular vagus nerve stimulation effective and safe for primary insomnia? A PRISMA-compliant protocol for a systematic review and meta-analysis
Yang et al. · PloS one · 2024 · Systematic Review / Meta-Analysis
Brain stimulation techniques as novel treatment options for insomnia: A systematic review
Krone et al. · Journal of sleep research · 2023 · Systematic Review / Meta-Analysis
Summary by Vagus Research. Always consult the primary source for the authoritative record.